glp-1 pharmacokinetics and the kidney: from physiology to pharmacology and outcomes in diabetes Science Behind GLP 1 GIP

Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E., & Gastaldon, C

If Im treating a diabetic patient on metformin who wants to try semaglutide, I usually add it and continue metformin until I see how their glucose levels respond, says Jennifer Brown, DO, ABOM, ABFM, a board-certified obesity and family medicine specialist at Maxwelton Health Center in West Virginia

The number of overweight people has been increasing rapidly in recent years due to genetic, socio-economic, lifestyle, and cultural influences

Known to trigger the release of insulin secretion, this peptide had so far proven disappointing as a drug candidate for treating diabetes

Quick Answer: Dulaglutide and once-weekly exenatide appear to have the lowest rates of nausea amongst GLP-1 receptor agonists, with approximately 1224% of patients affected compared with higher rates seen with other formulations